Author Archives: Warren Woessner

Warren Woessner Participates In Virtual Debate With Chris Hansen On The Myriad Lawsuit

Posted on August 17, 2009 by Warren Woessner

Cameron MacKendrick sponsors podcasts on issues of interest in IP law. In this one, I am trying to explain the debate surrounding both the patentability of “natural products” as well as the patentability of diagnostic assays and their relationship t … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , | Leave a comment

Journalism 101: Exergen Corporation v. Wal-Mart Stores, Inc.

Posted on August 10, 2009 by Warren Woessner

Attached below is an article by Ronald J. Schutz, Esq., that I think you’ll find interesting. Journalism 101.pdf

Posted in Litigation Issues | Tagged , , , | Leave a comment

David Kappos Confirmed as PTO Director

Posted on August 7, 2009 by Warren Woessner

Just minutes ago, the US Senate confirmed David Kappos as the new Under Secretary of Commerce for Intellectual Property and Director of the United States Patent & Trademark Office. On behalf of the leadership of AIPLA, I would like to … Continue reading →

Posted in USPTO Practice and Policy | Tagged , , , | Leave a comment

GENERICS (UK) LTD V DAIICHI PHARMACEUTICAL CO LTD – ENANTIOMER OF A KNOWN COMPOUND HELD PATENTABLE BY UK COURT OF APPEAL

Posted on August 4, 2009 by Warren Woessner

By Paul Cole The present dispute concerned the patentability of the enantiomeric quinoline antibiotic levofloxacin covered by Daiichi’s expired EP (UK) 0206283 and by a supplementary protection certificate (SPC) based on it. The racemic compound ofloxacin was known, and the … Continue reading →

Posted in Non-U.S. Practice | Tagged , , , , , , , , , | Leave a comment